-
1
-
-
2342462537
-
Bone quality: where do we go from here?
-
Bouxsein M.L. Bone quality: where do we go from here?. Osteoporos Int 2003, 14(Suppl. 5):S118-S127.
-
(2003)
Osteoporos Int
, vol.14
, Issue.SUPPL. 5
-
-
Bouxsein, M.L.1
-
2
-
-
33750607019
-
The role of cortical bone and its microstructure in bone strength
-
ii 27-31
-
Augat P., Schorlemmer S. The role of cortical bone and its microstructure in bone strength. Age Ageing 2006, 35(Suppl. 2). ii 27-31.
-
(2006)
Age Ageing
, vol.35
, Issue.SUPPL. 2
-
-
Augat, P.1
Schorlemmer, S.2
-
3
-
-
33751233831
-
Bone quality: what is it and how is it measured?
-
Compston J. Bone quality: what is it and how is it measured?. Arq Bras Endocrinol Metabol 2006, 50:579-585.
-
(2006)
Arq Bras Endocrinol Metabol
, vol.50
, pp. 579-585
-
-
Compston, J.1
-
6
-
-
34249656211
-
Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease
-
Chavassieux P., Seeman E., Delmas P.D. Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease. Endocr Rev 2007, 28:151-164.
-
(2007)
Endocr Rev
, vol.28
, pp. 151-164
-
-
Chavassieux, P.1
Seeman, E.2
Delmas, P.D.3
-
7
-
-
49549090015
-
The effect of the microscopic and nanoscale structure on bone fragility
-
Ruppel M.E., Miller L.M., Burr D.B. The effect of the microscopic and nanoscale structure on bone fragility. Osteoporos Int 2008, 19:1251-1265.
-
(2008)
Osteoporos Int
, vol.19
, pp. 1251-1265
-
-
Ruppel, M.E.1
Miller, L.M.2
Burr, D.B.3
-
8
-
-
0004851872
-
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. fracture intervention trial research group
-
Black D.M., Cummings S.R., Karpf D.B., Cauley J.A., Thompson D.E., Nevitt M.C., et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. fracture intervention trial research group. Lancet 1996, 348:1535-1541.
-
(1996)
Lancet
, vol.348
, pp. 1535-1541
-
-
Black, D.M.1
Cummings, S.R.2
Karpf, D.B.3
Cauley, J.A.4
Thompson, D.E.5
Nevitt, M.C.6
-
9
-
-
0032583492
-
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the fracture intervention trial
-
Cummings S.R., Black D.M., Thompson D.E., Applegate W.B., Barrett-Connor E., Musliner T.A., et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the fracture intervention trial. JAMA 1998, 280:2077-2082.
-
(1998)
JAMA
, vol.280
, pp. 2077-2082
-
-
Cummings, S.R.1
Black, D.M.2
Thompson, D.E.3
Applegate, W.B.4
Barrett-Connor, E.5
Musliner, T.A.6
-
10
-
-
0033552255
-
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. vertebral efficacy with risedronate therapy (VERT) study group
-
Harris S.T., Watts N.B., Genant H.K., McKeever C.D., Hangartner T., Keller M., et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. vertebral efficacy with risedronate therapy (VERT) study group. JAMA 1999, 282:1344-1352.
-
(1999)
JAMA
, vol.282
, pp. 1344-1352
-
-
Harris, S.T.1
Watts, N.B.2
Genant, H.K.3
McKeever, C.D.4
Hangartner, T.5
Keller, M.6
-
11
-
-
0037042498
-
Treatment of postmenopausal osteoporosis
-
Delmas P.D. Treatment of postmenopausal osteoporosis. Lancet 2002, 359:2018-2026.
-
(2002)
Lancet
, vol.359
, pp. 2018-2026
-
-
Delmas, P.D.1
-
12
-
-
10744232538
-
Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study
-
Hosking D., Adami S., Felsenberg D., Andia J.C., Valimaki M., Benhamou L., et al. Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study. Curr Med Res Opin 2003, 19:383-394.
-
(2003)
Curr Med Res Opin
, vol.19
, pp. 383-394
-
-
Hosking, D.1
Adami, S.2
Felsenberg, D.3
Andia, J.C.4
Valimaki, M.5
Benhamou, L.6
-
13
-
-
51349163043
-
Bisphosphonates: mechanism of action and role in clinical practice
-
Drake M.T., Clarke B.L., Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 2008, 83:1032-1045.
-
(2008)
Mayo Clin Proc
, vol.83
, pp. 1032-1045
-
-
Drake, M.T.1
Clarke, B.L.2
Khosla, S.3
-
14
-
-
44849118219
-
Treatment of premenopausal women with low bone mineral density
-
Cohen A., Shane E. Treatment of premenopausal women with low bone mineral density. Curr Osteoporos Rep 2008, 6:39-46.
-
(2008)
Curr Osteoporos Rep
, vol.6
, pp. 39-46
-
-
Cohen, A.1
Shane, E.2
-
15
-
-
44349185434
-
Risks and benefits of bisphosphonates
-
Coleman R.E. Risks and benefits of bisphosphonates. Br J Cancer 2008, 98:1736-1740.
-
(2008)
Br J Cancer
, vol.98
, pp. 1736-1740
-
-
Coleman, R.E.1
-
16
-
-
1642292806
-
Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy
-
Delmas P.D., Seeman E. Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone 2004, 34:599-604.
-
(2004)
Bone
, vol.34
, pp. 599-604
-
-
Delmas, P.D.1
Seeman, E.2
-
17
-
-
0033669403
-
Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis
-
Haguenauer D., Welch V., Shea B., Tugwell P., Adachi J.D., Wells G. Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis. Osteoporos Int 2000, 11:727-738.
-
(2000)
Osteoporos Int
, vol.11
, pp. 727-738
-
-
Haguenauer, D.1
Welch, V.2
Shea, B.3
Tugwell, P.4
Adachi, J.D.5
Wells, G.6
-
18
-
-
68949220946
-
Is bone quality associated with collagen age?
-
Leeming D.J., Henriksen K., Byrjalsen I., Qvist P., Madsen S.H., Garnero P., et al. Is bone quality associated with collagen age?. Osteoporos Int 2009, 20:1461-1470.
-
(2009)
Osteoporos Int
, vol.20
, pp. 1461-1470
-
-
Leeming, D.J.1
Henriksen, K.2
Byrjalsen, I.3
Qvist, P.4
Madsen, S.H.5
Garnero, P.6
-
19
-
-
0032032089
-
Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance
-
Knott L., Bailey A.J. Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance. Bone 1998, 22:181-187.
-
(1998)
Bone
, vol.22
, pp. 181-187
-
-
Knott, L.1
Bailey, A.J.2
-
20
-
-
0030087838
-
The effects of ageing and changes in mineral content in degrading the toughness of human femora
-
Currey J.D., Brear K., Zioupos P. The effects of ageing and changes in mineral content in degrading the toughness of human femora. J Biomech 1996, 29:257-260.
-
(1996)
J Biomech
, vol.29
, pp. 257-260
-
-
Currey, J.D.1
Brear, K.2
Zioupos, P.3
-
21
-
-
0032788395
-
Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength
-
Bailey A.J., Sims T.J., Ebbesen E.N., Mansell J.P., Thomsen J.S., Mosekilde L. Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int 1999, 65:203-210.
-
(1999)
Calcif Tissue Int
, vol.65
, pp. 203-210
-
-
Bailey, A.J.1
Sims, T.J.2
Ebbesen, E.N.3
Mansell, J.P.4
Thomsen, J.S.5
Mosekilde, L.6
-
22
-
-
0034802681
-
Spectroscopic characterization of collagen cross-links in bone
-
Paschalis E.P., Verdelis K., Doty S.B., Boskey A.L., Mendelsohn R., Yamauchi M. Spectroscopic characterization of collagen cross-links in bone. J Bone Miner Res 2001, 16:1821-1828.
-
(2001)
J Bone Miner Res
, vol.16
, pp. 1821-1828
-
-
Paschalis, E.P.1
Verdelis, K.2
Doty, S.B.3
Boskey, A.L.4
Mendelsohn, R.5
Yamauchi, M.6
-
23
-
-
70349135140
-
Spatial variation in osteonal bone properties relative to tissue and animal age
-
Gourion-Arsiquaud S., Burket J., Havill L., Dicarlo E., Doty S., Mendelsohn R., van der Meulen M., et al. Spatial variation in osteonal bone properties relative to tissue and animal age. J Bone Miner Res 2009, 24:1271-1281.
-
(2009)
J Bone Miner Res
, vol.24
, pp. 1271-1281
-
-
Gourion-Arsiquaud, S.1
Burket, J.2
Havill, L.3
Dicarlo, E.4
Doty, S.5
Mendelsohn, R.6
van der Meulen, M.7
-
24
-
-
42749086049
-
Failure of mineralized collagen fibrils: modeling the role of collagen cross-linking
-
Siegmund T., Allen M.R., Burr D.B. Failure of mineralized collagen fibrils: modeling the role of collagen cross-linking. J Biomech 2008, 41:1427-1435.
-
(2008)
J Biomech
, vol.41
, pp. 1427-1435
-
-
Siegmund, T.1
Allen, M.R.2
Burr, D.B.3
-
25
-
-
0028851590
-
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The alendronate phase III osteoporosis treatment study group
-
Liberman U.A., Weiss S.R., Broll J., Minne H.W., Quan H., Bell N.H., et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The alendronate phase III osteoporosis treatment study group. N Engl J Med 1995, 333:1437-1443.
-
(1995)
N Engl J Med
, vol.333
, pp. 1437-1443
-
-
Liberman, U.A.1
Weiss, S.R.2
Broll, J.3
Minne, H.W.4
Quan, H.5
Bell, N.H.6
-
26
-
-
12144289279
-
Ten years' experience with alendronate for osteoporosis in postmenopausal women
-
Bone H.G., Hosking D., Devogelaer J.P., Tucci J.R., Emkey R.D., Tonino R.P., et al. Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 2004, 350:1189-1199.
-
(2004)
N Engl J Med
, vol.350
, pp. 1189-1199
-
-
Bone, H.G.1
Hosking, D.2
Devogelaer, J.P.3
Tucci, J.R.4
Emkey, R.D.5
Tonino, R.P.6
-
27
-
-
0031722177
-
Human osteoclast formation and activity in vitro: effects of alendronate
-
Breuil V., Cosman F., Stein L., Horbert W., Nieves J., Shen V., et al. Human osteoclast formation and activity in vitro: effects of alendronate. J Bone Miner Res 1998, 13:1721-1729.
-
(1998)
J Bone Miner Res
, vol.13
, pp. 1721-1729
-
-
Breuil, V.1
Cosman, F.2
Stein, L.3
Horbert, W.4
Nieves, J.5
Shen, V.6
-
28
-
-
38849202528
-
Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies
-
Byrjalsen I., Leeming D.J., Qvist P., Christiansen C., Karsdal M.A. Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies. Osteoporos Int 2008, 19:339-348.
-
(2008)
Osteoporos Int
, vol.19
, pp. 339-348
-
-
Byrjalsen, I.1
Leeming, D.J.2
Qvist, P.3
Christiansen, C.4
Karsdal, M.A.5
-
29
-
-
63949084397
-
Spectroscopic markers of bone quality in alendronate-treated postmenopausal women
-
Boskey A.L., Spevak L., Weinstein R.S. Spectroscopic markers of bone quality in alendronate-treated postmenopausal women. Osteoporos Int 2009, 20:793-800.
-
(2009)
Osteoporos Int
, vol.20
, pp. 793-800
-
-
Boskey, A.L.1
Spevak, L.2
Weinstein, R.S.3
-
30
-
-
39049106609
-
Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra
-
Allen M.R., Gineyts E., Leeming D.J., Burr D.B., Delmas P.D. Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra. Osteoporos Int 2008, 19:329-337.
-
(2008)
Osteoporos Int
, vol.19
, pp. 329-337
-
-
Allen, M.R.1
Gineyts, E.2
Leeming, D.J.3
Burr, D.B.4
Delmas, P.D.5
-
31
-
-
49549114063
-
Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs
-
Saito M., Mori S., Mashiba T., Komatsubara S., Marumo K. Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs. Osteoporos Int 2008, 19:1343-1354.
-
(2008)
Osteoporos Int
, vol.19
, pp. 1343-1354
-
-
Saito, M.1
Mori, S.2
Mashiba, T.3
Komatsubara, S.4
Marumo, K.5
-
32
-
-
0035004850
-
Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles
-
Mashiba T., Turner C.H., Hirano T., Forwood M.R., Johnston C.C., Burr D.B. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 2001, 28:524-531.
-
(2001)
Bone
, vol.28
, pp. 524-531
-
-
Mashiba, T.1
Turner, C.H.2
Hirano, T.3
Forwood, M.R.4
Johnston, C.C.5
Burr, D.B.6
-
33
-
-
0346366454
-
Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs
-
Burr D.B., Miller L., Grynpas M., Li J., Boyde A., Mashiba T., et al. Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs. Bone 2003, 33:960-969.
-
(2003)
Bone
, vol.33
, pp. 960-969
-
-
Burr, D.B.1
Miller, L.2
Grynpas, M.3
Li, J.4
Boyde, A.5
Mashiba, T.6
-
34
-
-
33748175899
-
Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate
-
Allen M.R., Iwata K., Phipps R., Burr D.B. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Bone 2006, 39:872-879.
-
(2006)
Bone
, vol.39
, pp. 872-879
-
-
Allen, M.R.1
Iwata, K.2
Phipps, R.3
Burr, D.B.4
-
35
-
-
0034065559
-
Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib
-
Mashiba T., Hirano T., Turner C.H., Forwood M.R., Johnston C.C., Burr D.B. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 2000, 15:613-620.
-
(2000)
J Bone Miner Res
, vol.15
, pp. 613-620
-
-
Mashiba, T.1
Hirano, T.2
Turner, C.H.3
Forwood, M.R.4
Johnston, C.C.5
Burr, D.B.6
-
36
-
-
0034840104
-
Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures
-
Mashiba T., Turner C.H., Hirano T., Forwood M.R., Jacob D.S., Johnston C.C., et al. Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures. Bone 2001, 29:271-278.
-
(2001)
Bone
, vol.29
, pp. 271-278
-
-
Mashiba, T.1
Turner, C.H.2
Hirano, T.3
Forwood, M.R.4
Jacob, D.S.5
Johnston, C.C.6
-
37
-
-
0037370624
-
Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra
-
Komatsubara S., Mori S., Mashiba T., Ito M., Li J., Kaji Y., et al. Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra. J Bone Miner Res 2003, 18:512-520.
-
(2003)
J Bone Miner Res
, vol.18
, pp. 512-520
-
-
Komatsubara, S.1
Mori, S.2
Mashiba, T.3
Ito, M.4
Li, J.5
Kaji, Y.6
-
38
-
-
67349105623
-
Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate
-
Tang S.Y., Allen M.R., Phipps R., Burr D.B., Vashishth D. Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. Osteoporos Int 2009, 20:887-894.
-
(2009)
Osteoporos Int
, vol.20
, pp. 887-894
-
-
Tang, S.Y.1
Allen, M.R.2
Phipps, R.3
Burr, D.B.4
Vashishth, D.5
-
39
-
-
33745485305
-
Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women
-
Zoehrer R., Roschger P., Paschalis E.P., Hofstaetter J.G., Durchschlag E., Fratzl P., et al. Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women. J Bone Miner Res 2006, 21:1106-1112.
-
(2006)
J Bone Miner Res
, vol.21
, pp. 1106-1112
-
-
Zoehrer, R.1
Roschger, P.2
Paschalis, E.P.3
Hofstaetter, J.G.4
Durchschlag, E.5
Fratzl, P.6
-
40
-
-
84934439513
-
Fourier transform-infrared microspectroscopy and microscopic imaging
-
Gourion-Arsiquaud S., West P.A., Boskey A.L. Fourier transform-infrared microspectroscopy and microscopic imaging. Methods Mol Biol 2008, 455:293-303.
-
(2008)
Methods Mol Biol
, vol.455
, pp. 293-303
-
-
Gourion-Arsiquaud, S.1
West, P.A.2
Boskey, A.L.3
-
41
-
-
22144465558
-
Infrared spectroscopic characterization of mineralized tissues
-
Boskey A.L., Mendelsohn R. Infrared spectroscopic characterization of mineralized tissues. Vib Spectrosc 2005, 38:107-114.
-
(2005)
Vib Spectrosc
, vol.38
, pp. 107-114
-
-
Boskey, A.L.1
Mendelsohn, R.2
-
42
-
-
34547856587
-
Fourier transform infrared and Raman microspectroscopy and microscopic imaging of bone
-
Gourion-Arsiquaud S., Boskey A.L. Fourier transform infrared and Raman microspectroscopy and microscopic imaging of bone. Curr Opin Orthop 2007, 18:499.
-
(2007)
Curr Opin Orthop
, vol.18
, pp. 499
-
-
Gourion-Arsiquaud, S.1
Boskey, A.L.2
-
43
-
-
0034056155
-
Characterization of the trabecular rat bone mineral: effect of ovariectomy and bisphosphonate treatment
-
Bohic S., Rey C., Legrand A., Sfihi H., Rohanizadeh R., Martel C., et al. Characterization of the trabecular rat bone mineral: effect of ovariectomy and bisphosphonate treatment. Bone 2000, 26:341-348.
-
(2000)
Bone
, vol.26
, pp. 341-348
-
-
Bohic, S.1
Rey, C.2
Legrand, A.3
Sfihi, H.4
Rohanizadeh, R.5
Martel, C.6
-
44
-
-
0036137310
-
Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats
-
Bourrin S., Ammann P., Bonjour J.P., Rizzoli R. Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats. Bone 2002, 30:195-200.
-
(2002)
Bone
, vol.30
, pp. 195-200
-
-
Bourrin, S.1
Ammann, P.2
Bonjour, J.P.3
Rizzoli, R.4
-
45
-
-
11144353705
-
Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties
-
Day J.S., Ding M., Bednarz P., van der Linden J.C., Mashiba T., Hirano T., et al. Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties. J Orthop Res 2004, 22:465-471.
-
(2004)
J Orthop Res
, vol.22
, pp. 465-471
-
-
Day, J.S.1
Ding, M.2
Bednarz, P.3
van der Linden, J.C.4
Mashiba, T.5
Hirano, T.6
-
46
-
-
33646089442
-
Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite
-
Nancollas G.H., Tang R., Phipps R.J., Henneman Z., Gulde S., Wu W., et al. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone 2006, 38:617-627.
-
(2006)
Bone
, vol.38
, pp. 617-627
-
-
Nancollas, G.H.1
Tang, R.2
Phipps, R.J.3
Henneman, Z.4
Gulde, S.5
Wu, W.6
-
47
-
-
44149091703
-
Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro
-
Henneman Z.J., Nancollas G.H., Ebetino F.H., Russell R.G., Phipps R.J. Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro. J Biomed Mater Res A 2008, 84:993-1000.
-
(2008)
J Biomed Mater Res A
, vol.84
, pp. 993-1000
-
-
Henneman, Z.J.1
Nancollas, G.H.2
Ebetino, F.H.3
Russell, R.G.4
Phipps, R.J.5
-
48
-
-
33749259617
-
Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate
-
Durchschlag E., Paschalis E.P., Zoehrer R., Roschger P., Fratzl P., Recker R., et al. Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate. J Bone Miner Res 2006, 21:1581-1590.
-
(2006)
J Bone Miner Res
, vol.21
, pp. 1581-1590
-
-
Durchschlag, E.1
Paschalis, E.P.2
Zoehrer, R.3
Roschger, P.4
Fratzl, P.5
Recker, R.6
-
49
-
-
33748645515
-
Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats
-
Saito M., Fujii K., Mori Y., Marumo K. Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos Int 2006, 17:1514-1523.
-
(2006)
Osteoporos Int
, vol.17
, pp. 1514-1523
-
-
Saito, M.1
Fujii, K.2
Mori, Y.3
Marumo, K.4
-
50
-
-
0032835307
-
On the estrogen-bone relationship and postmenopausal bone loss: a new model
-
Frost H.M. On the estrogen-bone relationship and postmenopausal bone loss: a new model. J Bone Miner Res 1999, 14:1473-1477.
-
(1999)
J Bone Miner Res
, vol.14
, pp. 1473-1477
-
-
Frost, H.M.1
-
51
-
-
33845202518
-
Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women
-
Szulc P., Seeman E., Duboeuf F., Sornay-Rendu E., Delmas P.D. Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women. J Bone Miner Res 2006, 21:1856-1863.
-
(2006)
J Bone Miner Res
, vol.21
, pp. 1856-1863
-
-
Szulc, P.1
Seeman, E.2
Duboeuf, F.3
Sornay-Rendu, E.4
Delmas, P.D.5
-
52
-
-
18244385737
-
Bisphosphonate treatment of bone disease
-
Shaw N.J., Bishop N.J. Bisphosphonate treatment of bone disease. Arch Dis Child 2005, 90:494-499.
-
(2005)
Arch Dis Child
, vol.90
, pp. 494-499
-
-
Shaw, N.J.1
Bishop, N.J.2
-
53
-
-
32244434267
-
Bisphosphonate treatment of pediatric bone disease
-
Speiser P.W., Clarson C.L., Eugster E.A., Kemp S.F., Radovick S., Rogol A.D., et al. Bisphosphonate treatment of pediatric bone disease. Pediatr Endocrinol Rev 2005, 3:87-96.
-
(2005)
Pediatr Endocrinol Rev
, vol.3
, pp. 87-96
-
-
Speiser, P.W.1
Clarson, C.L.2
Eugster, E.A.3
Kemp, S.F.4
Radovick, S.5
Rogol, A.D.6
-
54
-
-
0027131374
-
A 20-year perspective on the mechanical properties of trabecular bone
-
Keaveny T.M., Hayes W.C. A 20-year perspective on the mechanical properties of trabecular bone. J Biomech Eng 1993, 115:534-542.
-
(1993)
J Biomech Eng
, vol.115
, pp. 534-542
-
-
Keaveny, T.M.1
Hayes, W.C.2
-
55
-
-
51049097232
-
Biomechanical effect of mineral heterogeneity in trabecular bone
-
Renders G.A., Mulder L., Langenbach G.E., van Ruijven L.J., van Eijden T.M. Biomechanical effect of mineral heterogeneity in trabecular bone. J Biomech 2008, 41:2793-2798.
-
(2008)
J Biomech
, vol.41
, pp. 2793-2798
-
-
Renders, G.A.1
Mulder, L.2
Langenbach, G.E.3
van Ruijven, L.J.4
van Eijden, T.M.5
-
56
-
-
19944433601
-
Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse
-
Misof B.M., Roschger P., Baldini T., Raggio C.L., Zraick V., Root L., et al. Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. Bone 2005, 36:150-158.
-
(2005)
Bone
, vol.36
, pp. 150-158
-
-
Misof, B.M.1
Roschger, P.2
Baldini, T.3
Raggio, C.L.4
Zraick, V.5
Root, L.6
-
57
-
-
33845890326
-
Effects of continuing or stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extension (FLEX): a randomized trial
-
Black D.M., Schwartz A.V., Ensrud K.E., Cauley J.A., Levis S., Quandt S.A., et al. Effects of continuing or stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extension (FLEX): a randomized trial. JAMA 2006, 296:2927-2938.
-
(2006)
JAMA
, vol.296
, pp. 2927-2938
-
-
Black, D.M.1
Schwartz, A.V.2
Ensrud, K.E.3
Cauley, J.A.4
Levis, S.5
Quandt, S.A.6
-
58
-
-
56749091799
-
Osteoporosis: how long should we treat?
-
Sebba A. Osteoporosis: how long should we treat?. Curr Opin Endocrinol Diabetes Obes 2008, 15:502-507.
-
(2008)
Curr Opin Endocrinol Diabetes Obes
, vol.15
, pp. 502-507
-
-
Sebba, A.1
-
59
-
-
65449151378
-
Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment
-
Geusens P. Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment. Curr Osteoporos Rep 2009, 7:12-17.
-
(2009)
Curr Osteoporos Rep
, vol.7
, pp. 12-17
-
-
Geusens, P.1
-
60
-
-
40949099444
-
Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate
-
Lenart B.A., Lorich D.G., Lane J.M. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 2008, 358:1304-1306.
-
(2008)
N Engl J Med
, vol.358
, pp. 1304-1306
-
-
Lenart, B.A.1
Lorich, D.G.2
Lane, J.M.3
-
61
-
-
67650468390
-
Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study
-
Lenart B.A., Neviaser A.S., Lyman S., Chang C.C., Edobor-Osula F., Steele B., et al. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int 2009, 20:1353-1362.
-
(2009)
Osteoporos Int
, vol.20
, pp. 1353-1362
-
-
Lenart, B.A.1
Neviaser, A.S.2
Lyman, S.3
Chang, C.C.4
Edobor-Osula, F.5
Steele, B.6
-
62
-
-
70350193337
-
Unusual mid-shaft fractures during long term bisphosphonate therapy
-
doi:10.111/j.1365226A.1009.03581
-
Odvina C.V., Levy S., Rao S., Zerwekh J.E., Sudhaker Rao D. Unusual mid-shaft fractures during long term bisphosphonate therapy. Clin Endocrinol (Oxf) 2009, doi:10.111/j.1365226A.1009.03581.
-
(2009)
Clin Endocrinol (Oxf)
-
-
Odvina, C.V.1
Levy, S.2
Rao, S.3
Zerwekh, J.E.4
Sudhaker Rao, D.5
-
63
-
-
13844257099
-
Role of bone turnover in microdamage
-
discussion S77-80
-
Schaffler M.B. Role of bone turnover in microdamage. Osteoporos Int 2003, 14(Suppl. 5):S73-S77. discussion S77-80.
-
(2003)
Osteoporos Int
, vol.14
, Issue.SUPPL. 5
-
-
Schaffler, M.B.1
-
64
-
-
38749123943
-
Modeling the onset and propagation of trabecular bone microdamage during low-cycle fatigue
-
Kosmopoulos V., Schizas C., Keller T.S. Modeling the onset and propagation of trabecular bone microdamage during low-cycle fatigue. J Biomech 2008, 41:515-522.
-
(2008)
J Biomech
, vol.41
, pp. 515-522
-
-
Kosmopoulos, V.1
Schizas, C.2
Keller, T.S.3
|